May 20, 2013
J.K. WallWith premiums for health insurance likely to head north next year as President Obama’s health care reform law fully
takes effect, both individuals and employers will pay for more health care out of their own funds and buy less insurance.
More
May 20, 2013
J.K. WallThe study results, which will be released Monday afternoon, are part of Indianapolis-based Lilly’s campaign to get Medicare
to pay for use of its brain imaging agent Amyvid.
More
May 20, 2013
IBJ Staff and Associated PressGreenwood officials three years ago approved $8.4 million of incentives for the Elona Biotechnologies project, including the
construction loan.
More
May 18, 2013
J.K. WallThe future of Indiana’s sprawling health care and life sciences industry might be threatened by an unlikely source:
smartphone apps.
More
May 17, 2013
IBJ convened a panel of experts at its Life Sciences Power Breakfast on May 10 to talk about the industry issues
of venture capital, digital health innovations and research university entrepreneurship.
Panel members included Kristin Eilenberg, CEO, Lodestone Logic, Infuse Accelerator; Philip S. Low, Purdue University professor
of chemistry, founder and chief science officer at Endocyte Inc. and On Target Laboratories LLC; R. Matthew Neff, president,
CHV Capital Inc.; Brian Stemme, project director; BioCrossroads; Brian S. Williams, director, Global Healthcare Strategy,
PricewaterhouseCoopers International Ltd.; and Raul Zaveleta, CEO, Indigo BioSystems Inc.
The following is an unedited transcript of the discussion.
More
May 16, 2013
Bloomberg NewsEli Lilly claims recent decisions by Canadian courts invalidating 17 drug patents have made the country an outlier among major
developed countries.
More
May 14, 2013
Greg AndrewsOutside observers cast the departures of Lenox Baker, Sheila Burke and Susan Bayh as a positive that will allow new CEO Joseph
Swedish to recast the board.
More
May 14, 2013
Bloomberg NewsEli Lilly and Co. CEO John Lechleiter underwent a scheduled surgery Monday for a heart defect, and the repair to the aorta
is functioning as intended, the Indianapolis-based drugmaker said.
More
May 13, 2013
Bloomberg NewsLenox Baker, Sheila Burke and Susan Bayh resigned from the board effective immediately, Indianapolis-based WellPoint said
Monday in a regulatory filing.
More
May 13, 2013
Associated PressDr. Jay Hess was picked to become the 10th dean in the school of medicine's 110-year history and the first dean in the past
five to come from outside IU.
More
May 13, 2013
J.K. WallThe state's medical-device companies are finding that they cannot pass on the new medical-device tax created by Obamacare
to their hospital customers, causing them to continue to make cuts and to look to foreign markets for more profitable growth.
More
May 13, 2013
Rather than raising prices on private health insurers to make up for inadequate payments from the government, hospitals across
the country have been raising prices just because they can, according to a new study.
More
May 11, 2013
The 133 full-time jobs the truck and auto insurer plans to add over the next five years will pay around $60 an hour, or nearly
$125,000 a year.
More
May 11, 2013
Greg AndrewsA federal bankruptcy judge has slapped down an Anderson church that attempted to blame its bank for a failed scheme to finance
church upgrades by buying life insurance policies on its elderly members.
More
May 10, 2013
Bloomberg NewsThe drug, enzastaurin, was in the most advanced stage of testing and had been expected to generate $260 million in annual
sales by 2018.
More
May 8, 2013
IBJ StaffWarner relies on funds from the Indiana Family and Social Administration, but the FSSA recently decided to end that funding
after numerous complaints against the company went unresolved.
More
May 7, 2013
J.K. WallThe appointment is the first high-profile post that Braly, 51, has accepted since she was ousted from the top spot at the
Indianapolis-based health insurer in August.
More
May 6, 2013
J.K. WallJohn Lechleiter has been suffering from a dilated aorta, Eli Lilly and Co. said Monday. Current CFO Derica Rice will take
his place until later this summer.
More
May 6, 2013
J.K. WallThe effort to launch the Indiana Biosciences Research Institute got $25 million from the Legislature, but the life sciences
institutions backing the effort have set their funding sights much higher.
More
May 6, 2013
J.K. WallLilly will eliminate 1,624 positions from its U.S. sales force in July, according to a notice the company made to state officials.
But some of those workers may be rehired by the firm.
More
May 6, 2013
Associated PressMajor drugmakers, including Indianapolis-based Eli Lilly and Co., are closely watching Pfizer Inc.'s plan to sell Viagra directly
to consumers. The bold move blows up the drug industry's distribution model.
More
May 4, 2013
J.K. WallInfuse Accelerator hopes to make early-stage investments in 12 to 15 companies a year.
More
April 30, 2013
Associated PressThe question of whether Indiana will expand Medicaid is now back in Gov. Mike Pence's hands, after lawmakers wrapped up
their session without mandating he expand coverage under the federal health care law or suggesting the route he should take.
More
April 29, 2013
J.K. WallAfter a four-month debate, the Legislature ended pretty much where it started on a potential expansion of Medicaid: Lawmakers
are letting Gov. Mike Pence go one-on-one with President Obama to see what kind of deal he can strike.
More
April 29, 2013
J.K. WallAccording to one estimate, the Indianapolis-based health insurer will shed $400 million in pre-tax profits by 2017.
More
First, the Athenaeum is going to have to get past the hurdle with the Lockerbie residents and the agreement that the parcel would be residential. Second, and in my opinion, this prime piece of property should include parking, PLUS, a black box theater(s), some market rate and affordable artist housing and a plan to renovate and reconfigure the second story theater. I would negotiate to add the DeHaan property surface parking lot into the development mix, place a one story surface parking garage on the DeHaan lot on the street level (for the Dehaan tenants use during the daytime) and add a second story to the garage that would become an addition to the current second story theater and then change the direction of the theater by moving the stage across the alley and on top of the DeHaan lot parking. You can add all the stage elements that are currently missing from the Athenaeum stage to make it more attractive for use by Ballet, Opera and traveling productions. Plus, the theater changes would probably help solve some of the soundproofing issues. Alas,it does not seem to be a part of the strategic plan to conduct a study to determine best use of the property. Seems like the current plan is a quick and easy move that ignores the property best use/potential and any strategic property planning for the effect on future generations.
I recall that MSA's pilings are still in the ground and hard to remove. It’s not likely any proposal will include significant underground construction/parking because of this. Start adding 2 floors of retail, 8 floors of parking and 5-10 floors of possible hotel, and/or 10-20 floors of residential, and you are at 30 floors already with possible expansion of all the uses. But then again I could be wrong.
Accoriding to their website there is no deadline to the Do Not Call list. What is this article referring to??
On what planet are they entitled to this largesse from the stockholders? These people make multi-million dollar salaries: Pay for your own personal travel.
It matters because they're already paid enormously fat salaries: Pay for your own personal travel. Being "taxed on it" isn't a valid excuse--so what? They're still being gifted a raft of luxury perks from somebody else's money on top of an enormous, lavish salary.